313 related articles for article (PubMed ID: 11961884)
1. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
Stipp D
Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
[No Abstract] [Full Text] [Related]
2. Big pharma swallows biotech's pride.
Huggett B
Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
[No Abstract] [Full Text] [Related]
3. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
4. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
5. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
6. Genzyme and Isis strike megadeal.
Mack GS
Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
[No Abstract] [Full Text] [Related]
7. Growing against the grain.
Boyle M
Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
[No Abstract] [Full Text] [Related]
8. This Dutchman is flying.
Watson N
Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
[No Abstract] [Full Text] [Related]
9. A very firm handshake: biotech's growing negotiating power.
Thiel KA
Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
[No Abstract] [Full Text] [Related]
10. Hyseq-Variagenics merger signals end of the line.
Hodgson J
Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
[No Abstract] [Full Text] [Related]
11. What mergers can do for you.
Acharya A
Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
[No Abstract] [Full Text] [Related]
12. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
Miletich JP
Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
[No Abstract] [Full Text] [Related]
13. Merck wipes Serono off Swiss biotech map.
Urquhart L
Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
[No Abstract] [Full Text] [Related]
14. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
15. Biotech's next big blowup?
Stires D
Fortune; 2002 Mar; 145(6):154. PubMed ID: 11913033
[No Abstract] [Full Text] [Related]
16. UK industry consolidation is slow despite big merger.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
[No Abstract] [Full Text] [Related]
17. Amgen asks judge for speedy ruling in patent case.
Nephrol News Issues; 1999 Dec; 13(12):14. PubMed ID: 11984928
[No Abstract] [Full Text] [Related]
18. Biotech jostles with pharma for slice of HIV market.
Katsnelson A
Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
[No Abstract] [Full Text] [Related]
19. New IGF drug stirs competition in growth factor segment.
Ratner M
Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
[No Abstract] [Full Text] [Related]
20. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
